PRINCETON, N.J. (PRWEB) May 01, 2019
Soterius, Inc., a uniquely positioned outsourced service provider with a focus on global safety, medical affairs, regulatory, and technology enabled solutions, announced that one of the top 5 global pharma company has selected Soterius for providing medical and scientific services for its North American operations.
“We are honored to be trusted with delivering highly sensitive medical and scientific services for one of the leading pharma companies in the world. Soterius continues with its drive to simplify & enrich operating processes and communication(s) with physicians, patients and regulatory authorities around the world” said Suneet Walia, Founder and CEO, Soterius. “Our colleagues are highly experienced professionals with significant experience in supporting the entire life cycle, of development to go-to-market, for drugs, vaccines and devices in markets across the world.”
Soterius is transforming the way in which pharma companies operate their safety, medical and scientific operations.
Soterius continues to build and acquire technology rights, assets and established platforms to provide a portfolio of connected service offerings to enhance the ability to provide high quality, cost effective, compliant, and efficient services to its global clients and regulators.
Soterius provides global safety, medical affairs, regulatory, and technology enabled solutions and services to clients in the Americas, Europe and Asia. Soterius founders and partners have years of experience in building thriving people and customer focused organizations that care deeply about people, compliance, and patient outcomes.